West Pharmaceutical Services (WST) 76.44 $WST
Shares of WST Up 29.9% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Jun 10, 1:11PM CDT
SmarTrend identified an Uptrend for West Pharmaceutical Services (NYSE:WST) on February 22nd, 2016 at $59.22. In approximately 4 months, West Pharmaceutical Services has returned 29.88% as of today's recent price of $76.91.
WST: 76.44 (-0.19)
West Introduces 1-3mL NovaPure® Plunger for Higher Volume Injections
PR Newswire - Tue Jun 07, 7:00AM CDT
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the availability of the 1-3mL NovaPure® plunger--an innovative, high-quality component for pre-filled delivery systems, designed to reduce particulate, ensure consistency of delivery and fit the changing needs of higher-volume injectable drug delivery systems. This new offering adds to West's current portfolio of NovaPure products, which includes the 1mL long NovaPure plunger and 13mm and 20mm NovaPure lyo and serum stoppers. West is showcasing the new 1-3mL NovaPure plunger among its portfolio of innovations in injectable drug packaging and delivery systems at booth #7544 at the 2016 BIO International Convention in San Francisco, Calif.
WST: 76.44 (-0.19)
West Pharmaceutical Services Has Returned 27.9% Since SmarTrend Recommendation (WST)
Comtex SmarTrend(R) - Fri Jun 03, 12:48AM CDT
SmarTrend identified an Uptrend for West Pharmaceutical Services (NYSE:WST) on February 22nd, 2016 at $59.22. In approximately 3 months, West Pharmaceutical Services has returned 27.89% as of today's recent price of $75.73.
WST: 76.44 (-0.19)
West to Present at Investor Conference in June
PR Newswire - Wed Jun 01, 7:00AM CDT
West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will present an overview of West's business at the Jefferies Healthcare Conference in New York, NY, on Wednesday, June 8, 2016 at 11:30 a.m. EDT.
WST: 76.44 (-0.19)
Uptrend Call Working As West Pharmaceutical Services Stock Rises 24.5% (WST)
Comtex SmarTrend(R) - Thu May 26, 1:21PM CDT
SmarTrend identified an Uptrend for West Pharmaceutical Services (NYSE:WST) on February 22nd, 2016 at $59.22. In approximately 3 months, West Pharmaceutical Services has returned 24.50% as of today's recent price of $73.72.
WST: 76.44 (-0.19)
West to Present at Two Investor Conferences in May
PR Newswire - Wed May 04, 12:00PM CDT
West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will be presenting an overview of West's business at two investor conferences in May. Management will present at the Bank of America Merrill Lynch 2016 Health Care Conference, Las Vegas, Nevada, on Wednesday, May 11, 2016, at 1:40 p.m. PDT and at the UBS Global Healthcare Conference, New York, New York, on Tuesday, May 24, 2016, at 4:00 p.m. EDT.
WST: 76.44 (-0.19)
West Pharmaceutical tops Street 1Q forecasts
Automated Insights - Thu Apr 28, 8:30AM CDT
EXTON, Pa. (AP) _ West Pharmaceutical Services Inc. (WST) on Thursday reported first-quarter profit of $22.1 million.
WST: 76.44 (-0.19)
West Makes Investment in NanoPass Technologies
PR Newswire Europe - Mon Apr 25, 6:01AM CDT
EXTON, Pennsylvania, April 25, 2016 /PRNewswire/ -- West Pharmaceutical Services, Inc. [http://www.westpharma.com/] , a global leader in innovative solutions for injectable drug administration, today announced a strategic investment in NanoPass Technologies Ltd. [http://www.nanopass.com/] This investment will provide West with access to NanoPass' knowledge and expertise in the growing area of intradermal drug delivery and future collaboration opportunities to bring new products to market. West's investment will also allow NanoPass to advance its clinical development efforts and support the launch of its microneedle-based device for intradermal delivery of vaccines and drugs.
WST: 76.44 (-0.19)
West Pharmaceutical Services Up 21.5% Since SmarTrend Uptrend Call (WST)
Comtex SmarTrend(R) - Wed Apr 20, 1:26AM CDT
SmarTrend identified an Uptrend for West Pharmaceutical Services (NYSE:WST) on February 22nd, 2016 at $59.22. In approximately 2 months, West Pharmaceutical Services has returned 21.52% as of today's recent price of $71.96.
WST: 76.44 (-0.19)
Global Prefilled Syringes Market Size Growth of 12.9% CAGR by 2020 - Analysis, Technologies & Forecast Report 2016-2020 - Key Vendors: Baxter International Inc, Becton Dickinson & Bespak Europe
M2 - Thu Feb 04, 10:03AM CST
Research and Markets (http://www.researchandmarkets.com/research/6tvbnq/global_prefilled) has announced the addition of the "Global Prefilled Syringes Market Size, Share, Development, Growth and Demand Forecast to 2020 - Industry Insights by Type (Glass Prefilled Syringe, Plastic Prefilled Syringe)" report to their offering. The global prefilled syringes market accounted for $3,905.1 million value in 2014, and it is expected to grow with a CAGR of 12.9% during 2015-2020. Among the various types, the glass prefilled syringes segment dominated the global prefilled syringes market, with 90.1% share in 2014. Report Coverage: - Provides comprehensive understanding of the market with the help of informed market outlook, opportunities, challenges, trends, size and growth, competitive analysis, major competitors and Porter analysis - Identifies the key drivers of growth and challenges of the key industry players. Also, assesses the future impact of the propellants and restraints on the market - Uncovers potential demands in the market - Porter analysis identifies competitive forces within the market - Provides information on the historical and current market size and the future potential of the market - Provides sizes of key regional markets using yardsticks of processes, segments, products, end user and technology, etc (as applicable) - Provides profiles of major competitors of the market including details of their operations, product and services, recent developments and key financial metrics. Profiles provide better understanding of competition as well as the demands of the market Companies Mentioned: - Baxter International Inc. - Becton Dickinson and Company - Bespak Europe Ltd. - Gerresheimer AG - Medtronic PLC. - Nipro Corporation - SCHOTT AG - Stevanato Group S.p.a. - Unilife Corporation - Vetter Pharma-Fertigung GmbH& Co. KG - Weigao Group - West Pharmaceutical Services Inc. - Ypsomed Holding AG Report Structure: 1. Research Scope and Methodology 2. Executive Summary 3. Market Outlook 4. Global Prefilled Syringes Market Size and Forecast (2014 - 2020) 6. Global Prefilled Syringes Market Breakdown by Geography 7. Competitive Analysis 8. Company Profiles and Strategic Developments 9. Appendix For more information visit http://www.researchandmarkets.com/research/6t..._prefilled
WST: 76.44 (-0.19), UNIS: 3.57 (-0.02), MDT: 85.71 (+0.01), BAX: 44.73 (+0.24)
West and Noble Collaborate to Improve Patient Education and Training for Self-Injection Systems
PR Newswire - Wed Jan 20, 9:12AM CST
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug containment and delivery, today announced that the company is collaborating with Noble®, a leader in patient-centric onboarding and training, to provide multisensory-based educational and training programs for self-injection systems. West will now have the ability to offer its pharmaceutical and biotech customers validated training solutions for the SmartDose® Electronic Wearable Injector and other innovative self-administration systems from West. This collaboration with Noble complements West's established relationships with other innovative design firms such as Insight Product Development and HealthPrize Technologies to enhance its patient-centric approach to drug delivery systems.
WST: 76.44 (-0.19)
Global Prefilled Syringes Market Analysis & Trends - Poised to Grow at a CAGR of Around 12.8% in the Next 5 Years to Reach Approximately $5.3 Billion by 2020
M2 - Thu Jan 14, 4:29AM CST
Research and Markets (http://www.researchandmarkets.com/research/2m8d34/global_prefilled) has announced the addition of the "Global Prefilled Syringes Market Analysis & Trends - Industry Forecast to 2020" report to their offering. The Global Prefilled Syringes Market is poised to grow at a CAGR of around 12.8% in the next 5 years to reach approximately $5.3 billion by 2020. This industry report analyzes the global markets for Prefilled Syringes across all the given segments in the research scope. It presents historical market data for 2012, 2013, 2014 revenue estimations are presented for 2015 and forecasts till 2020. The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. The report provides comprehensive market analysis across four major geographies such as North America, Europe, Asia Pacific and Other parts of the world. Report Highlights: - The report provides a detailed analysis with current and future market trends to identify the investment opportunities - Market forecasts till 2020, using estimated market values as the base numbers - Key market trends across the business segments, Regions and countries - Key developments and strategies observed in the market - In-depth company profiles of key players and upcoming prominent players - Market opportunities and recommendations for new investments Key Topics Covered: 1 Market Outline 2 Executive Summary 3 Market Overview 4 By Syringe type 5 By Design of syringe 6 By Therapeutic areas 7 By Application 8 By Geography 9 Leading Companies - Baxter International, Inc. - Becton, Dickinson & Co. - Bespak - Covidien - Gerresheimer AG - Medtronic PLC. - Nipro Corporation - Schott AG - Stevanato Group - Unilife Corporation - Vetter Pharma International GmbH - Weigao Group - West Pharmaceutical Services, Inc. - Ypsomed Holding AG For more information visit http://www.researchandmarkets.com/research/2m..._prefilled
WST: 76.44 (-0.19), BDX: 169.07 (-0.22), UNIS: 3.57 (-0.02), MDT: 85.71 (+0.01), BAX: 44.73 (+0.24)
West Announces New Organizational Structure
PR Newswire - Tue Jan 12, 6:00AM CST
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced a change to its organization and reporting structure that will support the Company in its next phase of growth and development. Beginning in 2016, the company will no longer operate two separate units for its Packaging and Delivery System businesses. West is establishing global Commercial, Operations and Innovation & Technology organizations in order to provide more comprehensive and tailored offerings to its customers across the Company's rich portfolio of products and services.
WST: 76.44 (-0.19)
Watch for West Pharmaceutical Services to Potentially Pullback After Gaining 1.38% Yesterday
Comtex SmarTrend(R) - Thu Dec 24, 6:21PM CST
West Pharmaceutical Services (NYSE:WST) traded in a range yesterday that spanned from a low of $60.90 to a high of $61.96. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $61.52 on volume of 58,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
WST: 76.44 (-0.19)
Uptrend Call Working As West Pharmaceutical Services Stock Rises 9.0% (WST)
Comtex SmarTrend(R) - Thu Dec 17, 7:54PM CST
SmarTrend identified an Uptrend for West Pharmaceutical Services (NYSE:WST) on October 26th, 2015 at $56.94. In approximately 2 months, West Pharmaceutical Services has returned 8.98% as of today's recent price of $62.05.
WST: 76.44 (-0.19)
West Announces Quarterly Dividend and Share Repurchase Program
Marketwired - Thu Dec 17, 7:00AM CST
West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors has approved a first-quarter 2016 dividend of $0.12 per share. The dividend will be paid on February 3, 2016 to shareholders of record as of January 20, 2016.
WST: 76.44 (-0.19)
Shares of WST Up 29.9% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Jun 10, 1:11PM CDT
SmarTrend identified an Uptrend for West Pharmaceutical Services (NYSE:WST) on February 22nd, 2016 at $59.22. In approximately 4 months, West Pharmaceutical Services has returned 29.88% as of today's recent price of $76.91.
WST: 76.44 (-0.19)
West Introduces 1-3mL NovaPure® Plunger for Higher Volume Injections
PR Newswire - Tue Jun 07, 7:00AM CDT
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the availability of the 1-3mL NovaPure® plunger--an innovative, high-quality component for pre-filled delivery systems, designed to reduce particulate, ensure consistency of delivery and fit the changing needs of higher-volume injectable drug delivery systems. This new offering adds to West's current portfolio of NovaPure products, which includes the 1mL long NovaPure plunger and 13mm and 20mm NovaPure lyo and serum stoppers. West is showcasing the new 1-3mL NovaPure plunger among its portfolio of innovations in injectable drug packaging and delivery systems at booth #7544 at the 2016 BIO International Convention in San Francisco, Calif.
WST: 76.44 (-0.19)
West Pharmaceutical Services Has Returned 27.9% Since SmarTrend Recommendation (WST)
Comtex SmarTrend(R) - Fri Jun 03, 12:48AM CDT
SmarTrend identified an Uptrend for West Pharmaceutical Services (NYSE:WST) on February 22nd, 2016 at $59.22. In approximately 3 months, West Pharmaceutical Services has returned 27.89% as of today's recent price of $75.73.
WST: 76.44 (-0.19)
West to Present at Investor Conference in June
PR Newswire - Wed Jun 01, 7:00AM CDT
West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will present an overview of West's business at the Jefferies Healthcare Conference in New York, NY, on Wednesday, June 8, 2016 at 11:30 a.m. EDT.
WST: 76.44 (-0.19)
Uptrend Call Working As West Pharmaceutical Services Stock Rises 24.5% (WST)
Comtex SmarTrend(R) - Thu May 26, 1:21PM CDT
SmarTrend identified an Uptrend for West Pharmaceutical Services (NYSE:WST) on February 22nd, 2016 at $59.22. In approximately 3 months, West Pharmaceutical Services has returned 24.50% as of today's recent price of $73.72.
WST: 76.44 (-0.19)
West to Present at Two Investor Conferences in May
PR Newswire - Wed May 04, 12:00PM CDT
West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will be presenting an overview of West's business at two investor conferences in May. Management will present at the Bank of America Merrill Lynch 2016 Health Care Conference, Las Vegas, Nevada, on Wednesday, May 11, 2016, at 1:40 p.m. PDT and at the UBS Global Healthcare Conference, New York, New York, on Tuesday, May 24, 2016, at 4:00 p.m. EDT.
WST: 76.44 (-0.19)
West Pharmaceutical tops Street 1Q forecasts
Automated Insights - Thu Apr 28, 8:30AM CDT
EXTON, Pa. (AP) _ West Pharmaceutical Services Inc. (WST) on Thursday reported first-quarter profit of $22.1 million.
WST: 76.44 (-0.19)
West Makes Investment in NanoPass Technologies
PR Newswire Europe - Mon Apr 25, 6:01AM CDT
EXTON, Pennsylvania, April 25, 2016 /PRNewswire/ -- West Pharmaceutical Services, Inc. [http://www.westpharma.com/] , a global leader in innovative solutions for injectable drug administration, today announced a strategic investment in NanoPass Technologies Ltd. [http://www.nanopass.com/] This investment will provide West with access to NanoPass' knowledge and expertise in the growing area of intradermal drug delivery and future collaboration opportunities to bring new products to market. West's investment will also allow NanoPass to advance its clinical development efforts and support the launch of its microneedle-based device for intradermal delivery of vaccines and drugs.
WST: 76.44 (-0.19)
West Pharmaceutical Services Up 21.5% Since SmarTrend Uptrend Call (WST)
Comtex SmarTrend(R) - Wed Apr 20, 1:26AM CDT
SmarTrend identified an Uptrend for West Pharmaceutical Services (NYSE:WST) on February 22nd, 2016 at $59.22. In approximately 2 months, West Pharmaceutical Services has returned 21.52% as of today's recent price of $71.96.
WST: 76.44 (-0.19)
Global Prefilled Syringes Market Size Growth of 12.9% CAGR by 2020 - Analysis, Technologies & Forecast Report 2016-2020 - Key Vendors: Baxter International Inc, Becton Dickinson & Bespak Europe
M2 - Thu Feb 04, 10:03AM CST
Research and Markets (http://www.researchandmarkets.com/research/6tvbnq/global_prefilled) has announced the addition of the "Global Prefilled Syringes Market Size, Share, Development, Growth and Demand Forecast to 2020 - Industry Insights by Type (Glass Prefilled Syringe, Plastic Prefilled Syringe)" report to their offering. The global prefilled syringes market accounted for $3,905.1 million value in 2014, and it is expected to grow with a CAGR of 12.9% during 2015-2020. Among the various types, the glass prefilled syringes segment dominated the global prefilled syringes market, with 90.1% share in 2014. Report Coverage: - Provides comprehensive understanding of the market with the help of informed market outlook, opportunities, challenges, trends, size and growth, competitive analysis, major competitors and Porter analysis - Identifies the key drivers of growth and challenges of the key industry players. Also, assesses the future impact of the propellants and restraints on the market - Uncovers potential demands in the market - Porter analysis identifies competitive forces within the market - Provides information on the historical and current market size and the future potential of the market - Provides sizes of key regional markets using yardsticks of processes, segments, products, end user and technology, etc (as applicable) - Provides profiles of major competitors of the market including details of their operations, product and services, recent developments and key financial metrics. Profiles provide better understanding of competition as well as the demands of the market Companies Mentioned: - Baxter International Inc. - Becton Dickinson and Company - Bespak Europe Ltd. - Gerresheimer AG - Medtronic PLC. - Nipro Corporation - SCHOTT AG - Stevanato Group S.p.a. - Unilife Corporation - Vetter Pharma-Fertigung GmbH& Co. KG - Weigao Group - West Pharmaceutical Services Inc. - Ypsomed Holding AG Report Structure: 1. Research Scope and Methodology 2. Executive Summary 3. Market Outlook 4. Global Prefilled Syringes Market Size and Forecast (2014 - 2020) 6. Global Prefilled Syringes Market Breakdown by Geography 7. Competitive Analysis 8. Company Profiles and Strategic Developments 9. Appendix For more information visit http://www.researchandmarkets.com/research/6t..._prefilled
WST: 76.44 (-0.19), UNIS: 3.57 (-0.02), MDT: 85.71 (+0.01), BAX: 44.73 (+0.24)
West and Noble Collaborate to Improve Patient Education and Training for Self-Injection Systems
PR Newswire - Wed Jan 20, 9:12AM CST
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug containment and delivery, today announced that the company is collaborating with Noble®, a leader in patient-centric onboarding and training, to provide multisensory-based educational and training programs for self-injection systems. West will now have the ability to offer its pharmaceutical and biotech customers validated training solutions for the SmartDose® Electronic Wearable Injector and other innovative self-administration systems from West. This collaboration with Noble complements West's established relationships with other innovative design firms such as Insight Product Development and HealthPrize Technologies to enhance its patient-centric approach to drug delivery systems.
WST: 76.44 (-0.19)
Global Prefilled Syringes Market Analysis & Trends - Poised to Grow at a CAGR of Around 12.8% in the Next 5 Years to Reach Approximately $5.3 Billion by 2020
M2 - Thu Jan 14, 4:29AM CST
Research and Markets (http://www.researchandmarkets.com/research/2m8d34/global_prefilled) has announced the addition of the "Global Prefilled Syringes Market Analysis & Trends - Industry Forecast to 2020" report to their offering. The Global Prefilled Syringes Market is poised to grow at a CAGR of around 12.8% in the next 5 years to reach approximately $5.3 billion by 2020. This industry report analyzes the global markets for Prefilled Syringes across all the given segments in the research scope. It presents historical market data for 2012, 2013, 2014 revenue estimations are presented for 2015 and forecasts till 2020. The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. The report provides comprehensive market analysis across four major geographies such as North America, Europe, Asia Pacific and Other parts of the world. Report Highlights: - The report provides a detailed analysis with current and future market trends to identify the investment opportunities - Market forecasts till 2020, using estimated market values as the base numbers - Key market trends across the business segments, Regions and countries - Key developments and strategies observed in the market - In-depth company profiles of key players and upcoming prominent players - Market opportunities and recommendations for new investments Key Topics Covered: 1 Market Outline 2 Executive Summary 3 Market Overview 4 By Syringe type 5 By Design of syringe 6 By Therapeutic areas 7 By Application 8 By Geography 9 Leading Companies - Baxter International, Inc. - Becton, Dickinson & Co. - Bespak - Covidien - Gerresheimer AG - Medtronic PLC. - Nipro Corporation - Schott AG - Stevanato Group - Unilife Corporation - Vetter Pharma International GmbH - Weigao Group - West Pharmaceutical Services, Inc. - Ypsomed Holding AG For more information visit http://www.researchandmarkets.com/research/2m..._prefilled
WST: 76.44 (-0.19), BDX: 169.07 (-0.22), UNIS: 3.57 (-0.02), MDT: 85.71 (+0.01), BAX: 44.73 (+0.24)
West Announces New Organizational Structure
PR Newswire - Tue Jan 12, 6:00AM CST
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced a change to its organization and reporting structure that will support the Company in its next phase of growth and development. Beginning in 2016, the company will no longer operate two separate units for its Packaging and Delivery System businesses. West is establishing global Commercial, Operations and Innovation & Technology organizations in order to provide more comprehensive and tailored offerings to its customers across the Company's rich portfolio of products and services.
WST: 76.44 (-0.19)
Watch for West Pharmaceutical Services to Potentially Pullback After Gaining 1.38% Yesterday
Comtex SmarTrend(R) - Thu Dec 24, 6:21PM CST
West Pharmaceutical Services (NYSE:WST) traded in a range yesterday that spanned from a low of $60.90 to a high of $61.96. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $61.52 on volume of 58,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
WST: 76.44 (-0.19)
Uptrend Call Working As West Pharmaceutical Services Stock Rises 9.0% (WST)
Comtex SmarTrend(R) - Thu Dec 17, 7:54PM CST
SmarTrend identified an Uptrend for West Pharmaceutical Services (NYSE:WST) on October 26th, 2015 at $56.94. In approximately 2 months, West Pharmaceutical Services has returned 8.98% as of today's recent price of $62.05.
WST: 76.44 (-0.19)
West Announces Quarterly Dividend and Share Repurchase Program
Marketwired - Thu Dec 17, 7:00AM CST
West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors has approved a first-quarter 2016 dividend of $0.12 per share. The dividend will be paid on February 3, 2016 to shareholders of record as of January 20, 2016.
WST: 76.44 (-0.19)
